Colorectal CancerHero of HopeMisconceptions About Colorectal Cancer
Melissa Marshall aims to correct common misconceptions people have about colorectal cancer and ostomy bags and hopes to empower other colorectal cancer survivors to overcome any shame they may feel.
Video Library – January 4, 2018 2017 Hero of Hope Patient Award™ winner
Recommended For You
Colorectal CancerHere are the drugs and financial support services available to patients receiving treatment for Colorectal Cancer.
Breast CancerHero of HopeKhadijat Fatai-Banwo’s HER2-positive breast cancer diagnosis changed her outlook on the world and inspired her to become a leading voice in advocating for cancer care to be a national health priority in Nigeria.
Colorectal CancerNew study results presented at the 2020 ASCO annual meeting suggest that there is a new standard of care for the first-line treatment of some patients with advanced colorectal cancer. This was the first study to compare the use of Keytruda (pembrolizumab), a PD-1 inhibitor, versus chemotherapy to see which is the best first treatment for patients with metastatic (spreading) colorectal cancer and microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) abnormalities.
Colorectal CancerThe use of first-line immunotherapy combination with Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) continues to show robust, long-term benefit in patients with microsatellite instability high (MSI-H) or with mismatch repair-deficient (dMMR) metastatic (spreading) colorectal cancer, according to new study results presented at the 2020 ASCO annual meeting.
Last modified: January 29, 2018
